BACCINO, Francesco Maria
 Distribuzione geografica
Continente #
NA - Nord America 7.649
AS - Asia 4.414
EU - Europa 3.583
SA - Sud America 708
Continente sconosciuto - Info sul continente non disponibili 403
OC - Oceania 81
AF - Africa 76
Totale 16.914
Nazione #
US - Stati Uniti d'America 7.360
CN - Cina 1.525
SG - Singapore 1.387
IT - Italia 858
BR - Brasile 555
VN - Vietnam 429
FR - Francia 425
IE - Irlanda 367
DE - Germania 348
KR - Corea 310
FI - Finlandia 298
SE - Svezia 298
UA - Ucraina 262
JP - Giappone 228
GB - Regno Unito 200
CA - Canada 182
PL - Polonia 120
HK - Hong Kong 107
TW - Taiwan 80
AU - Australia 76
AT - Austria 72
IN - India 72
ES - Italia 64
NL - Olanda 62
BD - Bangladesh 50
AR - Argentina 42
ID - Indonesia 39
MX - Messico 38
BE - Belgio 34
TR - Turchia 33
CO - Colombia 32
DK - Danimarca 31
CH - Svizzera 30
EC - Ecuador 26
RU - Federazione Russa 25
SA - Arabia Saudita 22
SN - Senegal 21
IQ - Iraq 18
ZA - Sudafrica 17
JM - Giamaica 16
NO - Norvegia 16
VE - Venezuela 16
PK - Pakistan 15
TH - Thailandia 14
PT - Portogallo 13
CL - Cile 12
MO - Macao, regione amministrativa speciale della Cina 11
MA - Marocco 10
MY - Malesia 10
PY - Paraguay 10
TT - Trinidad e Tobago 10
AE - Emirati Arabi Uniti 9
GR - Grecia 9
EG - Egitto 8
BB - Barbados 7
BS - Bahamas 7
EU - Europa 7
GT - Guatemala 7
IL - Israele 7
PE - Perù 7
LT - Lituania 6
PH - Filippine 6
TN - Tunisia 6
AL - Albania 5
HU - Ungheria 5
MD - Moldavia 5
NZ - Nuova Zelanda 5
OM - Oman 5
RS - Serbia 5
SV - El Salvador 5
UY - Uruguay 5
BG - Bulgaria 4
GE - Georgia 4
JO - Giordania 4
LB - Libano 4
NI - Nicaragua 4
RO - Romania 4
UZ - Uzbekistan 4
BH - Bahrain 3
CR - Costa Rica 3
ET - Etiopia 3
IR - Iran 3
LV - Lettonia 3
MT - Malta 3
NG - Nigeria 3
PR - Porto Rico 3
SI - Slovenia 3
AM - Armenia 2
AZ - Azerbaigian 2
BN - Brunei Darussalam 2
BO - Bolivia 2
CZ - Repubblica Ceca 2
DJ - Gibuti 2
DO - Repubblica Dominicana 2
HR - Croazia 2
KZ - Kazakistan 2
LC - Santa Lucia 2
MU - Mauritius 2
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
Totale 16.501
Città #
Beijing 834
Santa Clara 730
Singapore 679
San Jose 633
Ashburn 511
Chandler 476
Dublin 351
Houston 237
Ann Arbor 227
Fairfield 202
Villeurbanne 169
Jacksonville 166
Milan 164
Princeton 145
Medford 141
Los Angeles 134
Council Bluffs 132
Wilmington 124
Columbus 114
Buffalo 108
Redwood City 106
Warsaw 105
Ho Chi Minh City 104
The Dalles 103
Lauterbourg 99
Seattle 99
Cambridge 97
Hanoi 91
Nyköping 90
Torino 89
Woodbridge 85
Franklin 84
Dallas 78
Dearborn 76
Hong Kong 75
Rome 74
Pisa 72
Seoul 72
Shanghai 71
Toronto 64
Dong Ket 63
Vienna 63
São Paulo 57
Taipei 57
Tokyo 54
Guangzhou 47
New York 47
Nanjing 46
Turin 44
Helsinki 42
Hefei 41
Boardman 37
Boston 36
Chicago 32
Munich 32
Philadelphia 27
Amsterdam 26
Naples 26
Frankfurt am Main 25
Jakarta 25
Rio de Janeiro 25
Florence 23
Phoenix 23
Verona 23
Washington 23
Nuremberg 22
San Diego 21
Falls Church 20
Indianapolis 20
Norwalk 20
Brussels 18
Denver 18
Detroit 18
Fremont 18
Sydney 18
Hangzhou 17
Montreal 17
Shenyang 17
Atlanta 16
Belo Horizonte 16
Jinan 16
Orem 16
Turku 16
Wuhan 16
Bogotá 15
Duncan 15
Lachine 14
London 14
Palermo 14
Brooklyn 13
Chongqing 13
Columbia 13
Melbourne 13
Rochester 13
Barcelona 12
Da Nang 12
Haiphong 12
Madrid 12
San Francisco 12
Bologna 11
Totale 9.503
Nome #
Coming back: autophagy in cachexia 593
ß-hydroxy-ß-methylbutyrate (HMB) attenuates muscle and body weight loss in experimental cancer cachexia 560
Autophagic degradation contributes to muscle wasting in cancer cachexia 552
Novel investigational drugs mimicking exercise for the treatment of cachexia 493
JNK activation is required for TNFα-induced apoptosis in human hepatocarcinoma cells 411
Cytotoxic properties of clofibrate and other peroxisome proliferators: relevance to cancer progression 399
MuRF-1 and p-GSK3β expression in muscle atrophy of liver cirrhosis 384
Glutamine prevents myostatin hyperexpression and protein hypercatabolism induced in C2C12 myotubes by Tumor Necrosis Factor-alpha 359
Changes in myostatin signaling in non weight-losing cancer patients 319
Mechanism-based therapeutic approaches to cachexia 274
Early changes of muscle IGF-1 and myostatin gene expression in gastric cancer patients 253
Combined approach to counteract experimental cancer cachexia: eicosapentenoic acid and training exercise 247
Vitamin D and VDR in cancer cachexia and muscle regeneration 246
AUTOPHAGY OF METALLOTHIONEINS PREVENTS TNF-INDUCED OXIDATIVE STRESS AND TOXICITY IN HEPATOMA CELLS 236
Divergent pathways for TNF and C(2)-ceramide toxicity in HTC hepatoma cells 228
Muscle wasting and impaired myogenesis in tumor bearing mice are prevented by ERK inhibition 224
CASPASE 2 ACTIVATION AND ER STRESS DRIVE RAPID JURKAT CELL APOPTOSIS BY CLOFIBRATE 220
Interference with Ca 2+ -dependent proteolysis does not alter the course of muscle wasting in experimental cancer cachexia 213
Sphingosine mediates TNFalpha-induced lysosomal membrane permeabilization and ensuing programmed cell death in hepatoma cells 197
In vitro and in vivo conditional sensitization of hepatocellular carcinoma cells to TNF-induced apoptosis by Taxol 195
Ca(2+)-dependent proteolysis in muscle wasting. 182
Cellular distribution of lysosomal hydrolase activities in the regenerating rat liver. 179
Are antioxidants useful to treat skeletal muscle atrophy? 177
LYSOSOMAL MECHANISMS OF DEATH BY TNF IN HEPATOMA CELLS 176
Anticytokine strategies for the treatment of cancer-related anorexia and cachexia 163
CALCIUM INFLUX AND [CA2+](I) CHANGES INDUCED BY BASIC FIBROBLAST GROWTH-FACTOR IN BALB-C 3T3 CELLS 161
Acid phosphatase residual latent activity versus lysosome osmotic fragility in rat liver autophagy. 158
Differential modulation of TNf alpha-induced cell death by 3-methyladenine, an autophagy inhibitor 157
Residual latent activity of acid phosphatase in total rat liver homogenate: a parameter for autophagy? 150
Anticytokine treatment prevents the increase in the activity of ATP-ubiquitin- and Ca2+-dependent proteolytic systems in the muscle of tumour-bearing rats 147
Increase in ceramide level alters the lysosomal targeting of cathepsin D prior to onset of apoptosis in HT-29 colon cancer cells 147
Residual latent activity of acid phosphatase: autophagy-related variations and effects of cycloheximide. 146
Effect of fasting and glucagon on the residual latent activity of acid phosphatase in rat liver. 145
Activation of Ca2+-dependent proteolysis in skeletal muscle and heart in cancer cachexia 143
Ceramide does not mediate TNF toxicity in rat hepatoma cells 143
Muscle atrophy in experimental cancer cachexia: is the IGF-1 signaling pathway involved? 139
Modulations of the calcineurin/NF-AT pathway in skeletal muscle atrophy 138
Cloning and expression of two ornithine decarboxylase forms from HMOA cells. 137
Decreased osmotic fragility of rat liver lysosomes after cycloheximide treatment. 135
Lysis of rat liver lysosomes through incubation with 1-leucyl-glycine, substrate for a lysosomal dipeptidase. 134
Patogenesi dell'ipotrofia muscolare nella cachessia neoplastica: ruolo della via di segnalazione attivata da IGF-1 134
Altered pattern of lipid metabolism in patients with lung cancer 134
Transformation by oncogenic ras-p21 alters the processing and subcellular localization of the lysosomal protease cathepsin D. 133
Alterations of lipid and cholesterol metabolism in cahectic tumor-bearing rats are prevented by insulin 130
Potassium and calcium currents and action potentials in mouse Balb/c 3T3 fibroblasts 128
Sphingosine mediates TNF-induced lysosomal permeabilization and cell death in hepatoma cells 128
Deacetylase inhibitors modulate the myostatin/follistatin axis without improving cachexia in tumor-bearing mice 128
Mice lacking TNFa receptors 1 and 2 are resistant to death and fulminant liver injury induced by agonistic anti-Fas antibody 126
Cancer cachexia: from experimental models to patient management 125
Cancer cachexia: metabolic alterations and therapeutic approaches in an experimental model 123
Il TNF determina attivazione delle caspasi, ma morte caspasi-indipendente in cellule di epatoma di ratto 122
Anti-TNF treatment reverts increased muscle ubiquitin gene expression in tumour-bearing rats 122
Sustained calcium influx activated by basic fibroblast growth factor in Balb-C 3T3 fibroblasts. 121
Tissue protein turnover during liver carcinogenesis 119
High levels of proteolytic enzymes in the ascitic fluid and plasma of rats bearing the Yoshida AH-130 hepatoma 118
Anti-TNF treatment interferes with changes in lipid metabolism in a tumour cachexia model 118
Effect of 4-Hydroxynonenal on cell cycle progression and expression of differentiation-associated antigens in HL-60 cells. 117
Regulation of protein turnover versus growth state. Studies on the mechanism(s) of initiation of acidic vacuolar proteolysis in cells of stationary ascites hepatoma. 115
Potassium and calcium currents activated by Foetal Calf Serum in Balb-c 3T3 fibroblasts 114
MODULATIONS OF MYOSTATIN IN CANCER CACHEXIA. 113
Intracellular free iron and acidic pathways mediate TNF-induced death of rat hepatoma cells 113
Rapid and extensive lethal action of clofibrate on hepatoma cells in vitro 113
Effect of simvastatin administration in an experimental model of cancer cachexia 110
Two currents activated by Epidermal Growth Factor in EGFR-T17 fibroblasts 110
Protein kinases in the pathogenesis of muscle wasting 110
Skeletal muscle apoptosis is not increased in gastric cancer patients with mild-moderate weight loss 109
Interleukin-15 mediates reciprocal regulation of adipose and muscle mass: a potential role in body weight control 108
Muscle protein waste in tumor-bearing rats is effectively antagonized by a beta-adrenergic agonist (clenbuterol). Role of the ATP-ubiquitin-dependent proteolytic pathway 108
Peroxisome proliferators induce apoptosis in hepatoma cells. 107
Effect of dehydroepiandrosterone in the prevention of cancer- and diabetes-induced cachexia 106
Role of mitogen-induced calcium influx in the control of the cell cycle in Balb-c 3T3 fibroblasts 106
Effect of two aliphatic aldehydes, methylglyoxal and 4-hydroxypentenal, on the growth of Yoshida ascites hepatoma AH-130. 105
Endosomal-lysosomal proteolysis mediates death signalling by TNFa, not by etoposide, in L929 fibrosarcoma cells: evidence for an active role of cathepsin D 104
Increased muscle proteasome activity correlates with disease severity in gastric cancer patients 103
Muscle wasting in diabetic and in tumor-bearing rats: Role of oxidative stress 102
MYOSTATIN EXPRESSION IS UPREGULATED IN CANCER CACHEXIA. 101
Cancer cachexia, malnutrition, and tissue protein turnover in experimental animals 101
Statins, coenzyme Q10 and cachexia: what’s the link? 99
Pharmacological interference with tissue protein hypercatabolism in tumor-bearing rats 99
Regulation of protein degradation in neoplastic cells 99
Understanding the mechanisms of muscle wasting to improve the management of several pathologies 99
Lysosomal mechanisms of death in HTC rat hepatoma cells 96
Effect of c-ski overexpression on the development of cachexia in mice bearing the Lewis lung carcinoma 96
Reduced autophagic activity in primary rat hepatocellular carcinoma and ascites hepatoma cells 95
Human and hamster procathepsin D, although equally tagged with mannose-6-phosphates, are differentially targeted to lysosomes in transfected BHK cells. 94
Cholesterol metabolism in normal and neoplastic cell proliferation 94
Nutritional support in cancer 93
Regulation of cell turnover in the liver of tumour-bearing rats: occurrence of apoptosis 92
Resveratrol, a natural product present in wine, decreases tumour growth in a rat tumour model 91
Tumour necrosis factor-alpha mediates changes in tissue protein turnover in a rat cancer cachexia model 91
Skeletal muscle wasting in tumor-bearing rats is associated with MyoD down-regulation 90
Protein turnover regulations and mechanisms in neoplastic cells and host tissues 90
Cholesterol metabolism during the growth of a rat ascites hepatoma (Yoshida AH-130) 88
IGF-1 is down-regulated in experimental cancer cachexia 87
Increased muscle ubiquitin mRNA levels in gastric cancer patients 86
Interleukin-15 antagonizes muscle protein waste in tumour-bearing rats. 85
Modulations of the calcineurin/NF-AT pathway in diabetes-induced skeletal muscle atrophy. 83
Mechanisms of skeletal muscle depletion in wasting syndromes: role of the ATP-ubiquitin-dependent proteolysis 81
Effect of two aliphatic aldheydes, methylglyoxal and 4-hydroxypentenal, on the growth of Yoshida ascites hepatoma AH-130 80
Expression of protein kinase C-beta-1 confers resistance to TNF alpha and paclitaxel-induced apoptosis in HT-29 colon carcinoma cells 76
Totale 16.028
Categoria #
all - tutte 48.183
article - articoli 0
book - libri 0
conference - conferenze 4.202
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.385


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.049 0 0 57 56 71 79 91 70 52 89 188 296
2022/20231.466 185 116 40 131 126 380 131 83 147 22 64 41
2023/2024658 63 131 32 39 55 67 18 41 12 55 32 113
2024/20252.243 27 102 53 163 750 167 49 91 281 134 131 295
2025/20264.609 365 213 345 522 426 218 568 203 328 527 146 748
2026/2027939 268 548 123 0 0 0 0 0 0 0 0 0
Totale 16.914